The Patent Finder
US

Antidotes for Factor Xa Inhibitors and Methods of Using the Same

US 9,388,401 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 26, 2028 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,455,439, US 8,455,441, US 8,889,129, US 9,056,106, US 9,062,298), so the cap could be lower.

Filed Jul 21, 2014 as application 14/337,074 · Granted Jul 12, 2016
Base term plus 16 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2008 2028
Clock starts
Sep 26, 2008
Term ends
Sep 26, 2028
Granted
Jul 12, 2016
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
16
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,153,590, US 8,268,783, US 8,455,439, US 8,455,441, US 8,889,129, US 9,056,106, US 9,062,298, US 9,109,046.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 16 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 26, 2008, when application 12/239,651, the earliest non-provisional in its chain, was filed (this one was filed Jul 21, 2014)Sep 26, 2028High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+16 days, USPTO patent term adjustment recordOct 12, 2028High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,153,590, US 8,268,783, US 8,455,439, US 8,455,441, US 8,889,129, US 9,056,106, US 9,062,298, US 9,109,046)capped to Sep 26, 2028Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 26, 2028Medium confidence

This family

US 8,153,590In force
Jan 2034
Jan 2034
US 8,268,783In force
Feb 2029
Feb 2029
US 8,455,441In force
no later than Sep 2028
no later than Sep 2028
US 9,109,046In force
Jan 2029
Jan 2029
US 9,062,298In force
no later than Sep 2028
no later than Sep 2028
US 8,889,129In force
no later than Sep 2028
no later than Sep 2028
US 9,388,401this patent
Sep 2028
Sep 2028
US 9,587,233In force
Sep 2028
Sep 2028
8 of 14 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 22, 2014
Reel 33364, frame 309
Lu, Genmin; Phillips, David R.; Andre, Patrick; Sinha, UmaPortola Pharmaceuticals, Inc.Assignment of Assignor's Interest
Mar 18, 2019
Reel 48633, frame 673
Portola Pharmaceuticals, Inc.HCR Collateral Management, LLCSecurity Interest
Jul 2, 2020
Reel 53120, frame 925
HCR Collateral Management, LLCPortola Pharmaceuticals, Inc.Release of Security Interest
Dec 17, 2020
Reel 54795, frame 162
Portola Pharmaceuticals, Inc.Portola Pharmaceuticals, LLCChange of Name
Dec 17, 2020
Reel 54795, frame 630
Portola Pharmaceuticals, LLCAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jan 5, 2021
Reel 54899, frame 357
Portola Pharmaceuticals, Inc.Portola Pharmaceuticals, LLCCorrective Assignment to Correct the State of the Assignee Previously Recorded on Reel 054795 Frame 0162. Assignor(S) Hereby Confirms the Change of Name.
Feb 17, 2021
Reel 56014, frame 1
Alexion Pharma International Operations Unlimited CompanyAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Feb 17, 2021
Reel 56392, frame 716
Alexion Pharmaceuticals, Inc.Alexion Pharma International Operations Unlimited CompanyAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited